Literature DB >> 8079920

Serum hepatitis C virus RNA levels and liver injury in volunteer blood donors.

N Yuki1, N Hayashi, T Takehara, H Hagiwara, N Hiramatsu, M Naito, Y Kawanishi, K Katayama, A Kasahara, H Fusamoto.   

Abstract

OBJECTIVES: Liver histology in volunteer blood donors positive for serum hepatitis C virus RNA was investigated in relation to hepatitis C virus viremia levels.
METHODS: Twenty-one volunteer blood donors positive for serum hepatitis C virus RNA by polymerase chain reaction were monitored for at least 1 yr by monthly routine liver function tests and underwent liver biopsy. Liver histology findings were correlated with hepatitis C virus viremia levels assessed by a quantitative branched DNA assay.
RESULTS: Liver histology showed the features of chronic hepatitis in 20 (95%) patients. Only one of the seven patients with persistently normal aminotransferase levels during follow-up had normal liver histology, and the others had chronic hepatitis. Sera obtained the same day of the liver biopsy were shown to contain hepatitis C virus RNA of 10(5.7)-10(7.6) equivalent/ml (median 10(6.7)). The total histological activity index score (median 2, range 0-15) and the scores of portal inflammation (median 1, range 0-3), lobular inflammation (median 1, range 0-4) and piecemeal necrosis (median 0, range 0-5) correlated with viremia levels (r = 0.64, p < 0.01; r = 0.60, p < 0.01; r = 0.48, p < 0.05; and r = 0.49, p < 0.05, respectively).
CONCLUSIONS: These findings suggest that chronic hepatitis is frequently caused by hepatitis C virus infection irrespective of the serum aminotransferase levels, and high level hepatitis C virus replication is a contributory cause for liver injury in volunteer blood donor populations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8079920

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  8 in total

1.  Serum HCV-RNA and liver histologic findings in patients with long-term normal transaminases.

Authors:  G Montalto; A L Zignego; M I Ruggeri; C Giannini; M Soresi; M Monti; A Carroccio; G Careccia; D Di Martino; F Giannelli
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

Review 2.  Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups.

Authors:  H L Tillmann; M P Manns
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

3.  Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease.

Authors:  H L Tillmann; D F Chen; C Trautwein; V Kliem; A Grundey; A Berning-Haag; K Böker; S Kubicka; L Pastucha; W Stangel; M P Manns
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

4.  No significant changes in levels of hepatitis C virus (HCV) RNA by competitive polymerase chain reaction in blood samples from patients with chronic HCV infection.

Authors:  E Yoshimura; J Hayashi; K Ueno; Y Kishihara; K Yamaji; Y Etoh; S Kashiwagi
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

5.  Correlation between serum HCV RNA and aminotransferase levels in patients with chronic HCV infection.

Authors:  M G Ghany; T M Chan; R Sanchez-Pescador; M Urdea; A S Lok
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

6.  Hepatitis C virus replicative levels and efficiency of genotyping by specific PCR and antibody assay.

Authors:  N Yuki; N Hayashi; E Mita; H Hagiwara; K Ohkawa; K Katayama; Y Sasaki; A Kasahara; H Fusamoto; T Kamada
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

7.  Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels.

Authors:  C Renou; P Halfon; S Pol; P Cacoub; E Jouve; J P Bronowicki; J P Arpurt; H Rifflet; M Picon; X Causse; V Canva; J Denis; A Tran; M Bourliére; D Ouzan; A Pariente; S Dantin; L Alric; V Cartier; M Reville; S Caillat-Zucman
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

8.  Outcomes of interferon alpha and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransaminases.

Authors:  C-K Hui; A Monto; T Belaye; E Lau; T L Wright
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.